Raymond James Financial Services Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $675K | Buy |
64,338
+1,895
| +3% | +$19.9K | ﹤0.01% | 2417 |
|
|
2024
Q2 | $731K | Buy |
62,443
+5,161
| +9% | +$60.4K | ﹤0.01% | 2278 |
|
|
2024
Q1 | $1.21M | Sell |
57,282
-8,621
| -13% | -$182K | ﹤0.01% | 1950 |
|
|
2023
Q4 | $1.18M | Sell |
65,903
-49,059
| -43% | -$881K | ﹤0.01% | 1884 |
|
|
2023
Q3 | $1.89M | Buy |
114,962
+50,056
| +77% | +$824K | ﹤0.01% | 1536 |
|
|
2023
Q2 | $1.3M | Buy |
64,906
+23,119
| +55% | +$462K | ﹤0.01% | 1774 |
|
|
2023
Q1 | $790K | Sell |
41,787
-2,350
| -5% | -$44.4K | ﹤0.01% | 2056 |
|
|
2022
Q4 | $1M | Sell |
44,137
-10,798
| -20% | -$245K | ﹤0.01% | 1836 |
|
|
2022
Q3 | $1.45M | Sell |
54,935
-1,259
| -2% | -$33.3K | ﹤0.01% | 1607 |
|
|
2022
Q2 | $1.39M | Sell |
56,194
-3,302
| -6% | -$81.6K | ﹤0.01% | 1646 |
|
|
2022
Q1 | $1.98M | Buy |
59,496
+9,765
| +20% | +$324K | ﹤0.01% | 1497 |
|
|
2021
Q4 | $1.63M | Buy |
49,731
+988
| +2% | +$32.3K | ﹤0.01% | 1672 |
|
|
2021
Q3 | $2.04M | Buy |
48,743
+7,062
| +17% | +$296K | ﹤0.01% | 1474 |
|
|
2021
Q2 | $1.62M | Buy |
41,681
+14,966
| +56% | +$581K | ﹤0.01% | 1624 |
|
|
2021
Q1 | $911K | Buy |
+26,715
| New | +$911K | ﹤0.01% | 1910 |
|
|
2020
Q1 | – | Sell |
-12,498
| Closed | -$512K | – | 2729 |
|
|
2019
Q4 | $512K | Sell |
12,498
-9,405
| -43% | -$385K | ﹤0.01% | 1972 |
|
|
2019
Q3 | $780K | Sell |
21,903
-3,525
| -14% | -$126K | ﹤0.01% | 1624 |
|
|
2019
Q2 | $1.31M | Buy |
25,428
+10,753
| +73% | +$552K | 0.01% | 1343 |
|
|
2019
Q1 | $841K | Buy |
14,675
+5,491
| +60% | +$315K | ﹤0.01% | 1553 |
|
|
2018
Q4 | $385K | Buy |
9,184
+4,478
| +95% | +$188K | ﹤0.01% | 1841 |
|
|
2018
Q3 | $355K | Buy |
+4,706
| New | +$355K | ﹤0.01% | 2163 |
|